Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+42.7%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+42.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202419.58+197.6%
20236.58+72.6%
20223.81-43.4%
20216.74+470.4%
2020-1.82+14.7%
2019-2.13-